Clinical Trials in Massachusetts

Showing 121-140 of 8,511 trials

Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System

NCT04634916

A prospective, single-arm, multi-center post-market surveillance study of the BD® WavelinQ™ EndoAVF System for the Creation of Arteriovenous (AV) Fistula in Patients Requiring Dialysis.

Kidney Disease, End-StageEnd-stage Renal DiseaseArteriovenous Fistula

C. R. Bard280 participantsStarted Mar 2021

La Jolla, California, United States • San Francisco, California, United States • Jacksonville, Florida, United States +14 more locations

RECRUITINGNA26 miles

The CONFORM Pivotal Trial

NCT05147792

The CLAAS® device will be evaluated for safety and efficacy by establishing its performance is non-inferior to the commercially available WATCHMAN® and Amulet™ left atrial appendage closure devices in patients with non-valvular atrial fibrillation. Patients who are eligible for the trial will be randomized to receive either the CLAAS device or the WATCHMAN or Amulet™ devices and will be followed for 5 years after device implant.

Atrial FibrillationStroke

Conformal Medical, Inc1,600 participantsStarted May 2022

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +80 more locations

Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System

The CONFORM Pivotal Trial

Find Trials by Condition in Massachusetts

Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR)

Precision Diagnostics in Inflammatory Bowel Disease, Cellular Therapy and Transplantation (The PREDICT Trial)

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

A Study of DF6002 Alone and in Combination With Nivolumab

Resilience and Equity in Aging, Cancer, and Health (REACH)

A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies

Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers

A Study of Ponsegromab in People With Heart Failure

Study of DF1001 in Patients With Advanced Solid Tumors

Study of Long-Term Safety and Efficacy on Gene Therapy in Glycogen Storage Disease Type Ia

Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma

S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Advanced or Metastatic Solid Tumors

Study to Evaluate the Clinical Safety and Performance of the CorNeat KPro for Treatment of Corneal Blindness